Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Mosaic Chromosomal Alterations and Monoclonal B-Cell Lymphocytosis: Relationship and Risk of Hematologic Malignancies

Rosalie Griffin, Aswin Sekar, Sameer A. Parikh, Giulio Genovese, Dennis P. Robinson, Aaron D. Norman, Janet E. Olson, Kari G. Rabe, Nicholas J. Boddicker, Paul J. Hampel, Neil E. Kay, Timothy G. Call, James R. Cerhan, Esteban Braggio, Curtis A. Hanson, Caline M. Vachon, Tait D. Shanafelt, Benjamin L. Ebert, Susan L. Slager

Blood (2023) 142 (Supplement 1): 2690.

https://doi.org/10.1182/blood-2023-184696

Published: 2023

Journal Articles

Progression and survival of MBL: a screening study of 10 139 individuals

Susan L. Slager, Sameer A. Parikh, Sara J. Achenbach, Aaron D. Norman, Kari G. Rabe, Nicholas J. Boddicker, Janet E. Olson, Geffen Kleinstern, Connie E. Lesnick, Timothy G. Call, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Tait D. Shanafelt

Blood (2022) 140 (15): 1702–1709.

https://doi.org/10.1182/blood.2022016279

Published: 2022

Includes: Supplemental data

Journal Articles

Prevalence and Overall Survival of Low Count Monoclonal B-Cell Lymphocytosis (LC-MBL): A Screening Study of 8,297 Individuals from the Mayo Clinic Biobank

Susan L. Slager, Sameer A. Parikh, Sara J. Achenbach, Geffen Kleinstern, Nicholas J. Boddicker, Aaron D. Norman, Kari G. Rabe, Connie E. Lesnick, Timothy G. Call, Janet E. Olson, James R. Cerhan, Neil E. Kay, Celine M. Vachon, Esteban Braggio, Curtis A. Hanson, Tait Shanafelt

Blood (2021) 138 (Supplement 1): 2632.

https://doi.org/10.1182/blood-2021-153320

Published: 2021

Journal Articles

Relationship and Susceptibility to Serious Infections Among Monoclonal B-Cell Lymphocytosis (MBL), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Clonal Hematopoiesis (CH) Premalignant Conditions

Nicholas J. Boddicker, Sameer A. Parikh, Geffen Kleinstern, Aaron D. Norman, Kari G. Rabe, Timothy G. Call, Janet E. Olson, Angela Dispenzieri, David L Murray, S. Vincent Rajkumar, Shaji Kumar, James R. Cerhan, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Tait Shanafelt, Celine M. Vachon, Susan L. Slager

Blood (2021) 138 (Supplement 1): 3739.

https://doi.org/10.1182/blood-2021-151929

Published: 2021

Journal Articles

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

Geffen Kleinstern, PhD, J. Brice Weinberg, MD, Sameer A. Parikh, MD, Esteban Braggio, PhD, Dennis P. Robinson, Aaron D. Norman, MPH, Kari G Rabe, Celine M. Vachon, PhD, Connie E. Lesnick, Timothy G. Call, MD, Danielle M. Brander, MD, Janet E. Olson, PhD, James R. Cerhan, MD PhD, Neil E. Kay, MD, Curtis A. Hanson, MD, Richard R. Furman, MD, Tait Shanafelt, MD, Susan L. Slager, PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-136548

Published: 2020

Journal Articles

Association between the Risk of Low/High-Count Monoclonal B-Cell Lymphocytosis (MBL) and the Chronic Lymphocytic Leukemia (CLL) Polygenic Risk Score (PRS)

Geffen Kleinstern, PhD, Sara J. Achenbach, Dennis P. Robinson, Aaron D. Norman, Kari G. Chaffee, MS, Connie E. Lesnick, Sameer A. Parikh, MD, Timothy G. Call, MD, Janet E. Olson, PhD, James R. Cerhan, MD PhD, Neil E. Kay, MD, Curtis A. Hanson, MD, Tait D. Shanafelt, MD, Susan L. Slager, PhD

Blood (2018) 132 (Supplement 1): 5538.

https://doi.org/10.1182/blood-2018-99-116414

Published: 2018

Journal Articles

Platelet Reactivity and CD39 Ectonucleotidase Activities in Cryptogenic Stroke

Aaron J Marcus, MD, Joan HF Drosopoulos, PhD, Kim E Olson, MD, Ranjini Anand, MS, Dana Leifer, MD, Jorge R Kizer, MD

Blood (2012) 120 (21): 3397.

https://doi.org/10.1182/blood.V120.21.3397.3397

Published: 2012

Journal Articles

Platelet Reactivity and CD39 Ectonucleotidase Activities in Cryptogenic Stroke

Aaron J. Marcus, MD, Marinus Johan Broekman, PhD, Joan HF Drosopoulos, PhD, Kim E. Olson, MD, Dianne Pulte, MD, Jorge R. Kizer

Blood (2008) 112 (11): 3817.

https://doi.org/10.1182/blood.V112.11.3817.3817

Published: 2008

Journal Articles

Raft Localization and Nucleotidase Activity of CD39 Depends on Internal Proteolytic Cleavage

Kim E Olson, MD, Joan HF Drosopoulos, PhD, Ashley E Olson, BS, Marinus Johan Broekman, PhD, Aaron J Marcus, MD

Blood (2008) 112 (11): 3925.

https://doi.org/10.1182/blood.V112.11.3925.3925

Published: 2008

Journal Articles

Nucleotidase Activity of CD39/NTPDase1 Is Dependent on Internal Proteolytic Cleavage Which Contributes to Lipid Raft Localization.

Kim E. Olson, MD, Marinus Johan Broekman, PhD, Ashley E. Olson, BS, Dianne Pulte, MD, Aaron J. Marcus, MD

Blood (2007) 110 (11): 3634.

https://doi.org/10.1182/blood.V110.11.3634.3634

Published: 2007

Journal Articles

CD39/NTPDase-1 Expression Is Associated with Activation in T-Lymphocytes.

Dianne Pulte, MD, Marinus Johan Broekman, PhD, Joan Drosopoulos, PhD, Kim E. Olson, MD, Naziba Islam, MS, Aaron J. Marcus, MD

Blood (2006) 108 (11): 1733.

https://doi.org/10.1182/blood.V108.11.1733.1733

Published: 2006

Journal Articles

CD39/NTPDase1 Variants Identified in Human Neutrophils Regulate Antithrombotic Activity.

Kim E. Olson, MD, Dianne Pulte, MD, Marinus Johan Broekman, PhD, Ashley E. Olson, BS, Joan Drosopoulos, PhD, Naziba Islam, MS, Elgilda Musi, BS, MA, Aaron J. Marcus, MD

Blood (2005) 106 (11): 3088.

https://doi.org/10.1182/blood.V106.11.3088.3088

Published: 2005

Journal Articles

Generation of a Novel Engineered Murine Apyrase in Pichia Pastoris. Enzymatic Profile and Inhibition of Human Platelet Reactivity.

Kim E. Olson, MD, Joan H.F. Drosopoulos, PhD, Marinus J. Broekman, PhD, Naziba Islam, MS, Dianne Pulte, MD, Aaron J. Marcus, MD

Blood (2004) 104 (11): 1846.

https://doi.org/10.1182/blood.V104.11.1846.1846

Published: 2004

Journal Articles

Shed tumor gangliosides and progression of human neuroblastoma

L Valentino, T Moss, E Olson, HJ Wang, R Elashoff, S Ladisch

Blood (1990) 75 (7): 1564–1567.

https://doi.org/10.1182/blood.V75.7.1564.1564

Published: 1990

NARROW

Mosaic Chromosomal Alterations and Monoclonal B-Cell Lymphocytosis: Relationship and Risk of Hematologic Malignancies

Progression and survival of MBL: a screening study of 10 139 individuals

Prevalence and Overall Survival of Low Count Monoclonal B-Cell Lymphocytosis (LC-MBL): A Screening Study of 8,297 Individuals from the Mayo Clinic Biobank

Relationship and Susceptibility to Serious Infections Among Monoclonal B-Cell Lymphocytosis (MBL), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Clonal Hematopoiesis (CH) Premalignant Conditions

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

Association between the Risk of Low/High-Count Monoclonal B-Cell Lymphocytosis (MBL) and the Chronic Lymphocytic Leukemia (CLL) Polygenic Risk Score (PRS)

Platelet Reactivity and CD39 Ectonucleotidase Activities in Cryptogenic Stroke

Platelet Reactivity and CD39 Ectonucleotidase Activities in Cryptogenic Stroke

Raft Localization and Nucleotidase Activity of CD39 Depends on Internal Proteolytic Cleavage

Nucleotidase Activity of CD39/NTPDase1 Is Dependent on Internal Proteolytic Cleavage Which Contributes to Lipid Raft Localization.

CD39/NTPDase-1 Expression Is Associated with Activation in T-Lymphocytes.

CD39/NTPDase1 Variants Identified in Human Neutrophils Regulate Antithrombotic Activity.

Generation of a Novel Engineered Murine Apyrase in Pichia Pastoris. Enzymatic Profile and Inhibition of Human Platelet Reactivity.

Shed tumor gangliosides and progression of human neuroblastoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only